Veritable, L.P. Repligen Corp Transaction History

Veritable, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $218,898 - $292,559	-1,556 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$161.19 - $257.96 $11,444 - $18,315	71 Added 4.78%	1,556 $293,000
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $6,437 - $7,916	-26 Reduced 1.72%	1,485 $393,000
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $16,360 - $27,233	-84 Reduced 5.27%	1,511 $437,000
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $18,245 - $24,304	-110 Reduced 6.45%	1,595 $318,000
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $14,970 - $18,779	-83 Reduced 4.64%	1,705 $331,000
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $29,319 - $40,900	198 Added 12.45%	1,788 $343,000
Q3 2020 Nov 13, 2020	BUY	$122.51 - $158.27 $194,790 - $251,649	1,590 New	1,590 $235,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

Stay updated on Veritable, L.P. with notifications on news.